Non-Psychoactive Cannabinoid CBD for Alzheimer’s Disease (AD)

An increasing number of people are experiencing a range of neurodegenerative diseases – one of the saddest and most emotionally debilitating is Alzheimer’s Disease (AD). A non-psychoactive phytocannabinoid called CBD (Cannabidiol) has demonstrated in a multitude of research studies that it has antioxidant, anti-inflammatory, and neuroprotective properties.  Although […]

CBD’s Neuroprotective Effects – New Research from Redox Biology

New research from China discusses more applications for the non-psychoactive cannabinoid CBD (Cannabidiol). The researchers from this study explained that there are a variety of therapeutic properties of CBD (demonstrated in vivo and in vitro), including: neuroprotective, anti-inflammatory, immunomodulatory, anxiolytic, and antidepressant effects. Cannabis and hemp have been used for a variety […]

American Medical Association (AMA) Approves First Online Video Educational Program for Practitioners on CBD and the Endocannabinoid System

It was announced that there will be an online course “accredited through the University of Louisville in accordance with the American Medical Association (AMA) and the American Board of Medical Specialties (ABMS) educational requirements” that will provide a detailed explanation of the Endocannabinoid System or ECS.  The ECS has been shown to […]